Kiwi drug devastates COVID in the lab, team seeks funding for clinical trials

+News

Kiwi drug devastates COVID in the lab, team seeks funding for clinical trials

NZD

New Zealand Doctor

placebo respimat inhaler
The proposed COVID-19 drug would be inhaled using an inhaler like this.
“The only question is if it’s going to cause side effects – hopefully not as it’s a humanised molecule, but you never know until you do trials” T
References

Iwanaga N, Cooper L, Rong L, et al. Novel ACE2-IgG1 fusions with improved activity against SARS-CoV2. bioRxiv preprint (online 15 June).

https://www.biorxiv.org/content/10.1101/2020.06.15.152157v1.full.pdf